Key Takeaways
- Accenture (ACN) stock experienced its worst weekly decline on record, plunging nearly 25% following disappointing fiscal Q3 results
- TD Cowen dropped its rating to Hold from Buy, cutting its price target dramatically from $258 down to $150
- New bookings contracted 3% quarter-over-quarter, with executives attributing the weakness to deals postponed until fiscal 2027
- Truist Securities pointed to approximately $100 million in revenue headwinds stemming from Middle East geopolitical instability
- Earnings projections have been lowered by 14 analysts; while no Sell ratings exist, the Street sees limited catalysts for immediate recovery
Shares of Accenture (ACN) stock were hovering between $120 and $123 on Monday, continuing a devastating selloff from the previous week that resulted in a nearly 25% decline — marking the company’s most severe weekly drop in its trading history.
The sharp descent started Thursday when ACN plummeted 18% to close at $127.98 following the release of its fiscal third-quarter earnings. The company reported revenue of $18.7 billion, falling short of Wall Street’s $18.78 billion consensus estimate. Despite beating earnings expectations with adjusted EPS of $3.80 versus the projected $3.72, the upside surprise couldn’t counterbalance concerns about future growth prospects and a sequential bookings decline of 3%.
TD Cowen’s Bryan Bergin spearheaded Monday’s analyst downgrade activity, moving his rating on ACN from Buy to Hold while slashing his price objective to $150 from a previous $258.
“Our thesis anticipating resilience ahead of eventual recovery proved incorrect,” Bergin acknowledged in his note. He explained that maintaining an optimistic stance lacked justification “with metrics trending negatively.”
The bookings shortfall emerged as the primary concern. Bergin characterized the 3% quarterly contraction as unexpected, noting he had anticipated at least marginal positive growth.
Company leadership attributed the weakness to several major contracts being deferred into fiscal year 2027. However, Bergin observed that even accounting for an estimated $1 billion in delayed deals, managed services bookings would still have registered a decline — an outcome that would have tested investor confidence in growth trajectories under any circumstances.
Wall Street Slashes Price Objectives Across the Board
Truist Securities reduced its target price to $150 from $210 while maintaining its Hold stance. The firm identified approximately $100 million in revenue pressure linked to escalating tensions across the Middle East region, with impacts projected to persist through Q4 and potentially into subsequent quarters.
Truist had previously downgraded ACN several weeks ago, highlighting constrained client budgets, artificial intelligence-related revenue displacement, and mounting geopolitical uncertainties. Indirect consequences from the Iran situation began surfacing during the latter portion of Q3, with the firm anticipating that corporate decision-making timelines will continue to lengthen.
Jefferies analyst Surinder Thind similarly decreased his price target, bringing it down to $130 from $185 while retaining a Hold rating. Thind had identified deteriorating demand signals as early as March. He referenced reduced revenue and profit forecasts extending into calendar year 2027, emphasizing that geopolitical headwinds are compounding an already challenging environment for discretionary client spending.
RBC Capital reduced its target to $175 from $253. Guggenheim trimmed its objective to $185 from $225 but maintained its Buy recommendation.
Current Analyst Sentiment on ACN Stock
Among 30 firms monitored by FactSet, 17 maintain Buy or Overweight ratings on ACN. The remaining 13 assign Hold ratings. Notably, zero analysts currently recommend selling the stock.
Despite the absence of Sell ratings, InvestingPro data shows 14 analysts have reduced their earnings projections for the upcoming reporting period. The stock is trading close to its 52-week low of $125.60, with technical indicators including the RSI suggesting oversold conditions.
CEO Julie Sweet identified Middle East geopolitical tensions as a contributing factor to the quarter’s underperformance. The company has maintained its strategic focus on cybersecurity acquisitions and continues developing partnerships with OpenAI and Anthropic to advance its agentic artificial intelligence capabilities.
ACN stock was changing hands at $120.85 during Monday afternoon trading, representing an additional decline of approximately 5.6% for the session.
